| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/20/2000 | CA2346364A1 Method for determining transcription factor activity and its technical uses |
| 04/20/2000 | CA2346259A1 Means and methods for modulating stomata characteristica in plants |
| 04/20/2000 | CA2346155A1 Enzymatic synthesis of ssdna |
| 04/20/2000 | CA2346122A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 04/20/2000 | CA2346008A1 G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 04/20/2000 | CA2346006A1 Delta 6 fatty acid desaturase |
| 04/20/2000 | CA2345904A1 Nucleic acid molecules encodeing a branching enzyme from bacteria of the genus neisseria as well as methods for the production of .alpha.-1,6-branched .alpha.-1,4-glucans |
| 04/20/2000 | CA2345900A1 Selectively replicating viral vectors |
| 04/20/2000 | CA2345885A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | CA2345046A1 Materials and methods for the modification of plant cell wall polysaccharides |
| 04/20/2000 | CA2344990A1 Materials and methods for the modification of plant lignin content |
| 04/20/2000 | CA2344711A1 Expression and secretion of icil-1 receptor antagonist type ii |
| 04/20/2000 | CA2343356A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | CA2342314A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | CA2326675A1 Isolated peptides which bind to hla-b35 molecules |
| 04/20/2000 | CA2314004A1 Matrix-remodeling genes |
| 04/19/2000 | EP0994185A2 Method for culturing Langerhans islets cells |
| 04/19/2000 | EP0994184A2 Culture system for optimisation of stimulation of growth and differentiation of bone or cartilage cells |
| 04/19/2000 | EP0993470A2 Antibodies and other binding molecules specific for hepatitis b viral antigens |
| 04/19/2000 | EP0993469A1 COMPOUNDS ENCODING THE PROTECTIVE M-LIKE PROTEIN OF $i(STREPTOCOCCUS EQUI) AND ASSAYS THEREFOR |
| 04/19/2000 | EP0993468A1 Compositions and methods for activating genes of interest |
| 04/19/2000 | EP0598840B1 Human calcium channel compositions and methods |
| 04/19/2000 | EP0558676B1 Process for transforming monocotyledonous plants |
| 04/19/2000 | CN1251136A Plant with modified growth |
| 04/19/2000 | CN1251134A Neurotrophic factor NNT-1 |
| 04/19/2000 | CN1251132A Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 04/19/2000 | CN1251130A Isolated viable parasate intestinal cells |
| 04/19/2000 | CN1250782A Process for preparing antibody able to precisely recognize difference between cells |
| 04/19/2000 | CN1250667A Process for preparing genetically engineered polypeptide medicine with Chinese-medicinal materials as main raw material |
| 04/19/2000 | CN1051576C Prodn. of plant resistant to attacks by sclerotinia sclerotiorum by introduction of gene encoding oxalate oxidase |
| 04/18/2000 | US6051760 Synthetic DNA sequence having enhanced insecticidal activity in maize |
| 04/18/2000 | US6051756 Rapid, simple and efficient process by treating cells prepared from non-embryo brassica tissue with microprojectiles coated with nucleic acid, then identifying stable transformants |
| 04/18/2000 | US6051755 Modification of plant lipids and seed oils utilizing yeast SLC genes |
| 04/18/2000 | US6051750 Processing tissue source to form cell remnants; removing cell remnants from extracellular matrix without removing growth factors; fragmenting to form matrix particulates; processing polymer to form thread; coating thread with matrix particulate |
| 04/18/2000 | US6051693 Human monoclonal antibody which preferentially binds to neoplastic cell over a normal cell of same tissue type; for diagnosis, anticarcinogenic agents and antitumor agents |
| 04/18/2000 | US6051689 Receptor for the glucagon-like-peptide (GLP-1) |
| 04/18/2000 | US6051688 Amino acid sequence for polypeptide of at least 6 contiguous amino acids; for diagnosis and treatment of nervous system disorders; anticonvulsants; antiischemic/antihypoxic agents; antiepileptic agents; alzheimer's/parkinson's diseases |
| 04/18/2000 | US6051550 Materials and methods for controlling homopteran pests |
| 04/18/2000 | US6051432 Kit for producing autologous effector cells from extracts of human blood; includes apparatus for cell washing, culture, and purification and reagents like granulocyte-macrophage colony stimulating factor for culture and differentiation |
| 04/18/2000 | US6051430 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 04/18/2000 | US6051428 Transducing tumor cells with herpes simplex virus amplicon containing gene coding for cytokines, chemokines, cellular adhesion molecules, or costimulatory molecules which activate b or t-cells for transient expression of the protein |
| 04/18/2000 | US6051427 Retroviral packaging plasmid including retroviral helper dna lacking native enhancer and/or promoter of the viral 5' long terminal repeat, the psi function sequence and the 3' long terminal repeat, but encodes foreign regulatory sequences |
| 04/18/2000 | US6051425 Method for producing tissue formation and tissue culture kit |
| 04/18/2000 | US6051418 Hybrid proteins with modified activity |
| 04/18/2000 | US6051407 A dna encoding a protein; regulating the production of cellulose in prokaryotic and eukaryotic cells |
| 04/18/2000 | US6051404 A nucleic acid encoding a protein; vaccines for poultry |
| 04/18/2000 | US6051402 A nucleic acid encoding an anti-sickling beta-globin protein; gene therapy for sickle cell |
| 04/18/2000 | US6051401 Methods and constructs for protein expression |
| 04/18/2000 | US6051400 An expression system comprising of a polynucleotide encoding a protein; therapy and diagnosis of kidney diseases, cardiovascular disorders, strokes, alzheimer's disease; anticarcinogenic agents and antiinflammatory agents |
| 04/18/2000 | US6051387 Methods of determining the presence of a neoplasm with CLNH5- and CLNH11-specific antibodies |
| 04/18/2000 | US6051386 Introducing a stimulant to test cells of a pigment cell line expressing exogenous cell surface receptor to set an initial state of pigment disposition, contacting with test chemical; change in pigment disposition indicates an agonist |
| 04/18/2000 | US6051229 Human-human hybridom for neoplasms CLNH5 and CLNH11 specific antibody compositions |
| 04/18/2000 | US6051226 use of antibodies targeting the MN oncoprotein conjugated to an anticancer therapeutic agent such as drug or toxin for tissue targeted cancer therapy |
| 04/18/2000 | US6051221 BRK protein tyrosine kinase and encoding nucleic acid |
| 04/18/2000 | US6051218 Administering cell expressing interleukin-3 |
| 04/18/2000 | US6051217 Administering to patient with hematopoietic or immunodeficiency |
| 04/18/2000 | US6050935 Container assembly for intravaginal fertilization and culture and embryo transfer and method of intravaginal fertilization and culture employing such a container |
| 04/18/2000 | CA2198607C Cell separation apparatus and method |
| 04/18/2000 | CA2158984C Method for reproducing douglas-fir by somatic embryogenesis |
| 04/18/2000 | CA2092195C Retroviral packaging cell line |
| 04/17/2000 | CA2286530A1 Method for culturing langerhans islets and islet autotransplantation islet regeneration |
| 04/17/2000 | CA2284849A1 Episomally replicating vector, its preparation and use |
| 04/16/2000 | CA2284857A1 G protein coupled receptor a4 |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020612A2 Therapeutically active proteins in plants |
| 04/13/2000 | WO2000020601A2 Polyketide synthase enzymes and recombinant dna constructs therefor |
| 04/13/2000 | WO2000020599A1 Established cells |
| 04/13/2000 | WO2000020598A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | WO2000020596A1 Fungal transcriptional activator useful in methods for producing polypeptides |
| 04/13/2000 | WO2000020591A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 04/13/2000 | WO2000020590A2 G-protein coupled receptor proteins |
| 04/13/2000 | WO2000020587A2 Cancer associated antigens and uses therefor |
| 04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
| 04/13/2000 | WO2000020576A2 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein |
| 04/13/2000 | WO2000020574A2 Fusions of scaffold proteins with random peptide libraries |
| 04/13/2000 | WO2000020573A2 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| 04/13/2000 | WO2000020564A1 T cells mediating an immune response and methods of use |
| 04/13/2000 | WO2000020562A1 A novel lymphocyte population expressing intracellular mo2 |
| 04/13/2000 | WO2000020561A1 Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using |
| 04/13/2000 | WO2000020560A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
| 04/13/2000 | WO2000020458A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 04/13/2000 | WO2000020457A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 04/13/2000 | WO2000020452A2 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
| 04/13/2000 | WO2000020450A2 Calcium channel alpha-2/delta gene |
| 04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
| 04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 04/13/2000 | WO2000020445A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 04/13/2000 | WO2000020438A1 G protein-coupled receptor resembling the thrombin receptor |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000020432A1 Antisense modulation of bcl-x expression |
| 04/13/2000 | WO2000020039A1 Methods and adjuvants for stimulating mucosal immunity |
| 04/13/2000 | WO2000020037A1 A novel component in the hedgehog signalling pathway |
| 04/13/2000 | WO2000020025A2 Akt compositions for enhancing survival of cells |
| 04/13/2000 | WO2000020011A1 Isolated dna encoding human h3 histamine receptor |
| 04/13/2000 | WO2000019988A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 04/13/2000 | WO2000019828A1 METHODS FOR GENERATING ANTIGEN-REACTIVE T CELLS $i(IN VITRO) |
| 04/13/2000 | WO2000019806A1 High temperature-tolerant plants |
| 04/13/2000 | WO2000003028A3 Method for optimizing the production of adenovirus vectors |
| 04/13/2000 | WO2000003015A3 Human transport protein homologs |
| 04/13/2000 | WO2000003003A3 Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria |